Clinical Trial Update: Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 biomarker study evaluating PDR001 in combination with MCS110 in gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• MCS110
• PDR001

Snippet

Sponsor: Seoul National University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN